A detailed history of Pro Share Advisors LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 4,447 shares of ANIP stock, worth $287,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,447
Previous 4,043 9.99%
Holding current value
$287,854
Previous $222,000 38.29%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$54.2 - $69.69 $21,896 - $28,154
404 Added 9.99%
4,447 $307,000
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $22,995 - $30,882
472 Added 13.22%
4,043 $222,000
Q3 2023

Nov 13, 2023

BUY
$50.28 - $64.61 $179,549 - $230,722
3,571 New
3,571 $207,000
Q1 2020

May 15, 2020

SELL
$30.35 - $67.14 $124,617 - $275,676
-4,106 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$55.65 - $79.83 $24,597 - $35,284
-442 Reduced 9.72%
4,106 $253,000
Q3 2019

Nov 12, 2019

SELL
$64.7 - $85.39 $3,235 - $4,269
-50 Reduced 1.09%
4,548 $331,000
Q2 2019

Aug 13, 2019

SELL
$67.77 - $82.2 $36,189 - $43,894
-534 Reduced 10.41%
4,598 $378,000
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $1,787 - $2,751
39 Added 0.77%
5,132 $362,000
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $37,629 - $51,586
-914 Reduced 15.22%
5,093 $229,000
Q3 2018

Nov 14, 2018

SELL
$52.95 - $71.34 $15,514 - $20,902
-293 Reduced 4.65%
6,007 $340,000
Q2 2018

Aug 13, 2018

SELL
$56.38 - $68.08 $21,931 - $26,483
-389 Reduced 5.82%
6,300 $421,000
Q1 2018

May 14, 2018

SELL
$56.98 - $72.41 $59,487 - $75,596
-1,044 Reduced 13.5%
6,689 $389,000
Q4 2017

Feb 14, 2018

BUY
$53.3 - $74.56 $24,144 - $33,775
453 Added 6.22%
7,733 $498,000
Q3 2017

Nov 13, 2017

BUY
$43.46 - $52.49 $20,817 - $25,142
479 Added 7.04%
7,280 $382,000
Q2 2017

Aug 11, 2017

BUY
N/A
6,801
6,801 $318,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.13B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.